Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Ata de Congresso
|
Giant Magnetoresistance (GMR) sensors for 0.35µm CMOS technology sub-mA current sensingde Marcellis, Andrea ; Reig, C. ; Cubells, M. D. ; Madrenas, J. ; Cardoso, F. ; Cardoso, S. ; Freitas, P. P.IEEE SENSORS 2014 Proceedings, 2014, p.444-447IEEETexto completo disponível |
|
2 |
Material Type: Ata de Congresso
|
Nursing Clinical Documentation System Structured on NANDA-I, NOC, and NIC Classification SystemsPeres, Heloisa Helena C ; de Almeida Lopes M da Cruz, Diná ; Tellez, Michelle ; de Cassia Gengo e Silva, Rita ; dos S Diogo, Regina Celia ; Ortiz, Diley Cardoso F ; Ortiz, Dóris RStudies in health technology and informatics, 2015, Vol.216, p.943-943 [Periódico revisado por pares]NetherlandsTexto completo disponível |
|
3 |
Material Type: Ata de Congresso
|
Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumabJerusalem, G. H. ; Dieras, V. ; Cardoso, F. ; Bergh, J. ; Fasolo, A. ; Rorive, A. ; Manlius, C. ; Pylvaenaeinen, I. ; Sahmoud, T. ; Gianni, L.JOURNAL OF CLINICAL ONCOLOGY, 2008, Vol.26 (15_suppl), p.1057-1057 [Periódico revisado por pares]Texto completo disponível |
|
4 |
Material Type: Ata de Congresso
|
Sequential administration of sunitinib (SU) and docetaxel (D) in women with advanced breast cancer (ABC): an exploratory evaluationMariani, G. ; Cardoso, F. ; Besse-Hammer, T. ; Viganò, L. ; Liljegren, A. ; Verkh, L. ; Huang, X. ; Giorgetti, C. ; Bergh, J. ; Gianni, L.JOURNAL OF CLINICAL ONCOLOGY, 2008, Vol.26 (15_suppl), p.14534-14534 [Periódico revisado por pares]Texto completo disponível |
|
5 |
Material Type: Ata de Congresso
|
Understanding the current use of breast cancer multigene signatures in clinical practice across Europe: global results from the PROCURE ProjectHarbeck, N ; Curigliano, G ; Cardoso, F ; Gnant, M ; King, J ; Lænkholm, A-V ; Penault-Llorca, F ; Prat, AGeburtshilfe und Frauenheilkunde, 2022, Vol.82 (10) [Periódico revisado por pares]Rüdigerstraße 14, 70469 Stuttgart, Germany: Georg Thieme VerlagTexto completo disponível |
|
6 |
Material Type: Ata de Congresso
|
Multidimensional independent component analysisCardoso, J.-F.Proceedings of the 1998 IEEE International Conference on Acoustics, Speech and Signal Processing, ICASSP '98 (Cat. No.98CH36181), 1998, Vol.4, p.1941-1944 vol.4IEEETexto completo disponível |
|
7 |
Material Type: Ata de Congresso
|
BENEFIT ASSESSMENT OF NEW METASTATIC BREAST CANCER (MBC) TREATMENTS – A MULTI-STAKEHOLDER APPROACHGordon, Jenn ; Bernardini, Benato ; Biganzoli, Laura ; Cardoso, Fatima ; Espin, Jaime ; Miikkulainen, Kaisa ; Spence, Danielle ; Schuurman, Susanne ; Spitz, Sabine ; Wilking, Nils ; Zernik, Nicole ; Ujupan, SoniaBREAST, 2019, Vol.48, p.S34 [Periódico revisado por pares]Texto completo disponível |
|
8 |
Material Type: Ata de Congresso
|
Neoadjuvant pembrolizumab plus chemotherapy vs placebo plus chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 studyKummel, S ; Schmid, P ; Harbeck, N ; Takahashi, M ; Untch, M ; Boileau, JF ; Cortes, J ; McArthur, H ; Dent, R ; O'Shaughnessy, J ; Pusztai, L ; Foukakis, T ; Park, YH ; Hui, R ; Cardoso, F ; Denkert, C ; Zhu, Y ; Pan, W ; Karantza, V ; Fasching, PBREAST, 2023, Vol.68, p.S63 [Periódico revisado por pares]Texto completo disponível |
|
9 |
Material Type: Ata de Congresso
|
Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early TNBC: Surgical Outcomes from the Phase 3 KEYNOTE-522 StudyKummel, S ; Schmid, P ; Harbeck, N ; Takahashi, M ; Untch, M ; Boileau, JF ; Cortes, J ; McArthur, H ; Dent, R ; O'Shaughnessy, J ; Pusztai, L ; Foukakis, T ; Park, YH ; Hui, RN ; Cardoso, F ; Denkert, C ; Zhu, YL ; Pan, W ; Karantza, V ; Fasching, PAANNALS OF SURGICAL ONCOLOGY, 2023, Vol.30 (SUPPL 2), p.S295 [Periódico revisado por pares]Texto completo disponível |
|
10 |
Material Type: Ata de Congresso
|
Pembrolizumab or placebo plus chemotherapy followed by pembrolizumab or placebo for early-stage TNBC: Updated EFS results from the phase III KEYNOTE-522 studySchmid, P ; Cortes, J ; Dent, RA ; Pusztai, L ; McArthur, HL ; Kummel, S ; Denkert, C ; Park, YH ; Hui, R ; Harbeck, N ; Takahashi, M ; Foukakis, T ; Reynier, MAM ; Ferreira, MIR ; Im, SA ; Cardoso, F ; Ding, Y ; Pan, W ; Tryfonidis, KE ; O'Shaughnessy, JANNALS OF ONCOLOGY, 2023, Vol.34, p.S1257 [Periódico revisado por pares]Texto completo disponível |